The fundamental question, said NIH director Francis Collins, is, "why doesn’t immunotherapy work for all patients in all types of cancer, and what can we do about that?"
from Forbes Real Time https://www.forbes.com/sites/elliekincaid/2017/10/12/nih-and-11-pharmaceutical-companies-announce-215-million-collaboration/
via IFTTT
No comments:
Post a Comment